English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
×
Site Menu
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
PRNewsWire - Health
BioCity's ETA-Selective Antagonist SC0062 Granted Breakthrough Therapy Designation in China for Diabetic Kidney Disease with Albuminuria
BioCity's ETA-Selective Antagonist SC0062 Granted Breakthrough Therapy Designation in China for Diab...
Share this via
Full Coverage
CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China's NMPA
CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China's NMPA
Share this via
Full Coverage
Gold Coast Health Plan Announces Inaugural Grant Awards to Expand Health Care Access Across Ventura County
Gold Coast Health Plan Announces Inaugural Grant Awards to Expand Health Care Access Across Ventura ...
Share this via
Full Coverage
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter
Share this via
Full Coverage
First
Prev.
74
75
76
77
78
79
80
Next
Last
Trending
1.
Joann's closing
2.
Texas Tech basketball
3.
UNC basketball
4.
Monster Hunter Wilds
5.
Ketamine
6.
Macron
7.
UPMC Memorial shooting
8.
Eagles
9.
Hims stock
10.
Joel Embiid
Popular News
The mortgage market hopes for rate cuts amid war moves
1 week ago
15
The mortgage market hopes for rate cuts amid war moves
Share this via
BrightGene präsentiert positive Phase-2-Daten für den Dual-G...
1 week ago
13
BrightGene präsentiert positive Phase-2-Daten für den Dual-GLP-1R/GIPR-Agonisten zur Gewichtsregulat...
Share this via
Ukraine returns bodies of 3 Russian soldiers repatriated as ...
1 week ago
11
Ukraine returns bodies of 3 Russian soldiers repatriated as remains of Ukrainians, Interior Ministry...
Share this via
BrightGene presenteert positieve fase 2 gegevens voor de dua...
1 week ago
11
BrightGene presenteert positieve fase 2 gegevens voor de duale GLP-1R/GIPR agonist voor gewichtsbehe...
Share this via
BrightGene présente des données positives de phase 2 pour so...
1 week ago
9
BrightGene présente des données positives de phase 2 pour son agoniste double GLP-1R/GIPR dans la ge...
Share this via